BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27288395)

  • 21. Trial-related blood sampling and red blood cell transfusions in preterm infants.
    Lewis AE; Kappel SS; Hussain S; Sangild PT; Zachariassen G; Aunsholt L
    Acta Paediatr; 2023 Dec; 112(12):2486-2492. PubMed ID: 37565393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?
    Meyer MP; Haworth C; McNeill L
    S Afr Med J; 1996 Mar; 86(3):251-3. PubMed ID: 8658295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cell transfusion thresholds in extremely low birth weight infants II.
    Grace E; Keir A
    Acta Paediatr; 2021 Sep; 110(9):2658-2659. PubMed ID: 34121226
    [No Abstract]   [Full Text] [Related]  

  • 24. Hematopoietic growth factors: Part II.
    Wandstrat TL; Wolfe M
    Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?
    Franz AR; Pohlandt F
    Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F96-F100. PubMed ID: 11207224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial.
    Kamholz KL; Dukhovny D; Kirpalani H; Whyte RK; Roberts RS; Wang N; Mao W; Zupancic JA;
    Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F93-8. PubMed ID: 21733926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lead content of blood transfusions for extremely low-birth-weight infants.
    Elabiad MT; Hook RE
    Am J Perinatol; 2013 Oct; 30(9):765-70. PubMed ID: 23322387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red cell transfusion thresholds for preterm infants: finally some answers.
    Bell EF
    Arch Dis Child Fetal Neonatal Ed; 2022 Mar; 107(2):126-130. PubMed ID: 33906941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International survey of transfusion practices for extremely premature infants.
    Guillén U; Cummings JJ; Bell EF; Hosono S; Frantz AR; Maier RF; Whyte RK; Boyle E; Vento M; Widness JA; Kirpalani H
    Semin Perinatol; 2012 Aug; 36(4):244-7. PubMed ID: 22818544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EBNEO Commentary: Red blood cell transfusion thresholds in extremely low birthweight infants.
    Grace E; Hilditch C; Keir A
    Acta Paediatr; 2021 Aug; 110(8):2476-2477. PubMed ID: 33710679
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of serum ischemia-modified albumin levels in anemia of prematurity.
    Erol S; Unal S; Demirel N; Kulali F; Isik DU; Aksu U; Bas AY
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3133-3138. PubMed ID: 28783992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
    Arif B; Ferhan K
    Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion.
    Whyte RK; Kirpalani H; Asztalos EV; Andersen C; Blajchman M; Heddle N; LaCorte M; Robertson CM; Clarke MC; Vincer MJ; Doyle LW; Roberts RS;
    Pediatrics; 2009 Jan; 123(1):207-13. PubMed ID: 19117884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity".
    Christensen RD
    Pediatrics; 1989 May; 83(5):793-6. PubMed ID: 2717299
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfusion practices in infants receiving assisted ventilation.
    Cohen A; Manno C
    Clin Perinatol; 1998 Mar; 25(1):97-111. PubMed ID: 9523077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of erythropoietin in neonates.
    Ohls RK
    Clin Perinatol; 2000 Sep; 27(3):681-96. PubMed ID: 10986635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the practice of transfusion in the anemia in preterm infants].
    Elguazzar S; Alaoui AM; Izgua AT
    Rev Med Brux; 2013; 34(1):4-11. PubMed ID: 23534309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues in transfusing preterm infants in the NICU.
    Bain A; Blackburn S
    J Perinat Neonatal Nurs; 2004; 18(2):170-82; quiz 183-4. PubMed ID: 15214254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.